INTRODUCTION
late and soluble fractions: Ca 2+ -dependent cPKCa, and b Ca 2+ -independent nPKC d, e and aPKCz isoforms. 2, 3 It has been reported that the profiles of PKCa and -b are modified during the early stage of diethylnitrosamine (DEN)-induced hepatocarcinogenesis. 4 Decreased expressions of PKCa and -b and increased expression of PKCe during the early stages of liver carcinogenisis were induced by DEN. 5 To understand the details of PKC isozyme intervention in processes such as hepatocarcinogenesis, the identification of specific PKC isoforms and their subcellular distribution appears to be of importance. The translocation of PKC from the cytosol to the membrane allows the enzyme to have access to several membrane protein substrates, many of which are involved in the signal transduction of factors that influence mitogenesis. Protein kinase C translocation has often been described as part of the pleiotropic response to mitogens and tumor promoters; 6, 7 however, little is known about the specific role of isoforms during liver carcinogenesis, particularly in cirrhosis-related hepatic carcinogenesis.
Liver cirrhosis is induced by a chronic liver injury such as viral hepatitis, alcoholic hepatitis and parasitic diseases, which consequently cause an imbalance in the proliferation of hepatocytes. The cirrhotic liver is characterized by a nodular regeneration of the parenchyma fibrosis and frequently by hyperplasia of the bile duct. 8 A fibrogenic response following tissue inflammation is observed in both human and animal cirrhosis, strongly suggesting that animal models are essential in the study of hepatic fibrosis. Different models of hepatic fibrosis display various pathologic features of fibrotic development; however, they are generally similar to those observed in humans. Liver cirrhosis is considered to be one of the major pathogenetic factors of human liver cancer 9 and the existence of a positive association between liver cirrhosis and the development of hepatocellular carcinoma (HCC) in humans is generally accepted. 10 Therefore, rodent carcinogenesis models have frequently been used to determine the relationship between cirrhosis and neoplastic lesions of the liver. 11, 12 Thioacetamide (TAA) and carbon tetrachloride (CCl 4 ) are classic hepatotoxic reagents that induce liver cirrhosis. 13, 14 It has been shown that regenerative nodules and liver fibrosis in treated rats are more prominent in the TAA-induced cirrhotic model than in that induced by CCl 4 , and that histology of the TAA model resembles more closely that of human cirrhosis. 15 As membrane translocation of each PKC isozyme has been reported to be an indicator of activation, 16 the present study was designed to examine subcellular re-distribution of PKC isoforms among particulate and soluble fractions of the rat cirrhotic liver induced by these two types of cirrhotic agents.
METHODS

Animal and chemical treatment
Five-week-old male F344 rats were purchased from Shizuoka Laboratory Animal Center (Shizuoka, Japan). The rats were randomized by bodyweight, and five rats per cage were housed. The housing conditions were 22 ± 2°C, 50 ± 10% humidity, and a 12-h light-dark cycle. The rats were fed a NIH-07 diet and had water ad libitum throughout the experimental period.
Rats were treated by the schedule shown in Fig. 1 . Phenobarbital sodium (Luminal, Daewon Pharmaceuticals, Seoul, Korea) in drinking water (0.05%) was administered to all animals for 1 week. The animals were then subdivided into three groups, groups 1, 2, and 3 (25 rats per group). Group 1 animals were maintained as controls. Group 2 animals were treated with 10% carbon tetrachloride (CCl 4 Tedia, Fairfeild, OH, USA) in 0.5 mL corn oil per kg bodyweight by intubation, three times per week for 8 weeks. Group 3 animals were given 0.03% thioacetamide (TAA Sigma Chemical Co. St Louis MO, USA) in drinking water throughout the remainder of the experimental period (until week 30; Fig. 1 ).
Histopathological examination
Animals of each group were killed in weeks nine, 20 and 30, and body and liver weights were recorded.The livers were removed rapidly and fixed in 10% formalin and then dehydrated and paraffin-embedded. Serial sections of 2-3 mm thickness were cut and the sections were HE stained for quantitative assessment of fibrosis, which was carried out by using a numerical scoring system based on the density of fibrous septa.
Detection of collagen content
Collagen content was detected by using the method previously described. 17 Briefly, two sections of liver, adjacent to those used for the histopathological studies, were cut to approximately 15 mm in thickness.The evaluation of collagen content was based on the colorimetric evaluation published by Lopez-De Leon and Rojikind. 18 The liver sections were deparaffinized and incubated in aluminum foil-covered test tubes in the presence of a 0.04% solution of Fast green FCF (dye for collagen deter mination) in saturated picric acid for 15 min. The sections were then washed with water and incubated in the presence of Fast green FCF 0.1% and Sirius red F3B 0.04% for 30 min. The eluted color induced by 0.05N NaOH in 50% methanol was read by using a spectrophotometer (Bio-Rad Microplate Reader, Hercules, CA, USA) at 530 and 605 nm. To quantitate the absorbance found for each dye, the color equivalences determined from the relationship obtained between the absorbances by using the colorimetric and the chemical methods of collagen and total protein determination of the same liver section were used.
Subcellular fractionation
Fresh liver (1 g) was homogenized in a cold sucrose buffer (0.25 mmol/L) containing PKC lysis buffer (20 mmol/L Tris-HCl (pH 7.5), 5 mmol/L EDTA, 1 mmol/L phenylmethylsulfonyl fluoride and 40 mg/mL leupeptin). The mixture was briefly centrifuged and the supernatant was set aside. After brief sonication, the lysate was centrifuged at 100 000 g for 1 h, and the supernatant was taken as the soluble fraction.The pellet was resuspended in PKC lysis buffer containing 1% Triton X-100 and centrifuged as before; the supernatant was then removed and used as the particulate fraction. The protein concentration was determined by using the Bio-Rad protein assay.
Immunoblotting
Fifty mg protein samples were diluted with sodium dodecyl sulfate (SDS) sample buffer (5 mmol/L Tris, 10% glycerol, 2% SDS, 2% b-mercaptoethanol, 0.02% bromphenol blue, pH 6.8) and separated by using 8.5% acrylamide sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were transferred electrophoretically to nitrocellulose and the membranes were blocked in 5% milk. To detect PKC isoforms, the membranes were incubated with antibodies specific to the catalytic subunits of PKCa, -b and -d at a dilution of 2 mg/mL (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) and PKCe at a dilution of 1:1000 (Gibco, BRL, Gaithersburg, MD, USA). Proteins were detected by using the ECL system (Amersham, Arlington Heights, IL, USA) with horseradish peroxidaseconjugated secondary antibody (Bio-Rad, Hercules, CA, USA) at a dilution of 1:5000. Immunoblots were quantitated by using an MCID software program (Imaging Research Inc., Ontario, Canada).
The Student's t-test was used for statistical analysis.
RESULTS
Histopathological changes
As shown in Fig. 2 , prominent liver features of the rats treated chronically with CCl 4 were fatty changes in the hepatocytes and centrolobular fibrosis. Liver parenchyma was surrounded by a thick fibrous capsule, which consisted primarily of fibrotic connective tissue and a modest proliferation of ductule cells. Many hepatocytes became enlarged and possessed prominent nucleoli. Hepatic cords were disorganized and contained enlarged hepatocytes. Extensive fibrous encapsulation and fatty changes were observed at week nine, but these lesions regressed at week 20. The TAAinduced fibrotic pattern differed from that induced by CCl 4 , because it was characterized by the formation of fibrous connective tissue and proliferation of bile ductule cells. In portal areas, increased connective tissues were observed in the hyperplastic bile ductule cells and the activated stellated (Ito) cells.These epithelial cells had a bile duct-like structure with small oval pale-blue stained nuclei and basophilic cytoplasm, and 9 weeks 30 weeks 20 weeks proliferated markedly during weeks 20 and 30. Aggregations of hyperplastic bile ductular cells were not restricted to the portal area, as it also extended into the surrounding liver parenchyma. In the rats continuously treated with TAA, cholangiofibrosis was typically observed, and this comprised proliferating ductules and a large amount connective tissue. At week 30, the incidence of hyperplastic bile ducts increased compared to week 9 or 20. Particularly, small hepatocytes with basophilic cytoplasm and clear cell foci were also detected in TAA-treated rats.
Collagen content
Because increased collagen content was an indicator of progressive hepatic cirrhosis, 17 colorimetric measurement of hepatic collagen content was attempted. As shown in Fig. 3 , collagen content significantly increased in both CCl 4 and TAA-treated rats; peak induction was at week nine in CCl 4 treated rats and at week 30 in TAA-treated rats. In CCl 4 -treated rats, induced collagen content recovered to the control level at week 30, which coincided with the result of morphologic changes. Rats treated with TAA also showed increased collagen content that was also consistent with the result of morphologic changes.
Subcellular redistribution of each PKC isozyme
The effect of CCl 4 or TAA treatment on the subcellular distribution of each PKC isoform in whole liver is shown in Fig. 4 . The PKCa in the cytosolic fraction indicated a dramatic decrease at week 9 in CCl 4 -treated rats, which coincided with the peak induction of cirrhotic liver.The total amount of PKCa protein was very low, suggesting that PKCa protein had already been activated and then downregulated by proteolytic degradation. Its expression was recovered at week 20. Even at control levels, PKCa in the particulate fraction was a little increased, which may because of the aging process. Translocation of PKCb1 was detected in only one case; however, in other cases, it was not expressed in the cytosolic fraction, which meant that PKCb1 might be activated and downregulated by proteolytic degradation. A slight translocation of PKCd in CCl 4 -treated rats was seen at week 9, but it recovered to the control level at week 20. The PKCe in CCl 4 -treated rats behaved the same way as PKCa. In the case of TAAtreated rats, translocation of PKCb1 to the particulate fraction occured at week 9 and lasted until week 20, and then returned to the control level at week 30, whereas the translocation of PKCa, -d and -e was seen at week 9 and lasted until week 30.
DISCUSSION
Although changes in PKC activity and the expression of several PKC isozymes have been reported to occur in normal livers, the exact mechanisms involved in the alteration of PKC expression have not yet been characterized during liver cirrhosis. The present result on subcellular redistribution of PKC isozymes demonstrated that they were activated both by CCl 4 and TAA treatments.
Our findings showed that the translocation of PKC isozymes to the membrane fraction was induced by chemical treatments and that PKC isozyme translocation usually preceded morphologic changes associated with cirrhosis. When morphologic changes were examined, peak cirrhosis was observed at week nine of CCl 4 treatment and week 30 of TAA treatment (Fig. 2) . The collagen content was also consistent with morphologic changes (Fig. 3) , which indicated that it was correlated with morphologic fibrotic changes, as suggested by others. 16 The expressions of PKC isozymes, including PKCa, -b1 and -d, decreased in the cytosol of CCl 4 -treated rats in week nine, but in the particulate fractions they were similar to the controls.This is consistent with the notion that endogenous activators of PKC are present in the liver and that they may sustain the activation of PKC, leading to its down-regulation and altered subcellular distribution. In contrast to the above, all the PKC isozymes in the TAA-treated rats were translocated from week 9 and they were continuously translocated until week 20 or 30. Recently, down-regulation of PKC catalytic activity was demonstrated to be closely associated with hyperplasia and tumor promotion, and was believed to be because of the fact that PKC isozymes might have specific functions. 19, 20 It was possible that the sustained translocation, which suggests that there may be activation and/or down-regulation of one or more of the PKC isozymes, occured during the induction of cirrhosis. In the present study, PKCe expression in the particulate fraction increased markedly after TAA treatment. Because PKCe expression is related to cancer development, 20, 21 the morphology of TAAtreated rat liver indicated that they initiate/promote more in the carcinogenesis stage.
Regardless of the types of cirrhotic agents employed, PKC activation occured, meaning that PKC activation was not caused by chemical damage, but rather because of altered signaling pathways. All the PKC isozymes presently investigated showed a similar response to cirrhotic agents. Target sites may be common to all the PKC isozymes, because the PKC isozymes have conserved structures, however, one targeted isozyme may alternatively affect other isozymes. In CCl 4 -treated rats, downregulation of PKCd was slower than the other PKC isozymes and the kinetics of PKCb1 was faster than the other PKC isozymes in TAA-treated rats.
In conclusion, our results suggest that liver cirrhosis, regardless of chemical inducers, is accompanied by subcellular redistribution of PKC isozymes and these changes may be involved in the initiation of liver carcinogenesis. Figure 4 Western blots demonstrating hepatic response of protein kinase C (PKC) isozymes in cytosolic and particulate fraction of rat liver after carbon tetrachloride (CCl 4 ) or thioacetamide (TAA) treatment, autopsied at (i) 9, (ii) 20 and (iii) 30 weeks; (a) groups of two or three mice were killed and cytosolic and membrane extracts of each liver were prepared, subjected to sodium dodec ylsulf ate-polyacr ylamide gel electrophoresis (50 mg protein/lane) and transferred to a nitrocellulose membrane. Isozyme-specific antibodies for PKCa, -b1, -d, and -e were used for immunoblotting, (b) the relative band density of blots was quantitated. (ᮀ) Soluble, () particulate. *Significantly different from the control rats at P < 0.05. Refer to page 39 for part (b). 
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